Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Fukuda

Showing results (191-200 of 254) with videos related to

Pageof 26
Sort By:
Clinical Lung Cancer|January 24, 2012
Phase I and II trials of vinorelbine with carboplatin for patients 75 years of age or older with previously untreated non-small-cell lung cancerHiroshi Takatani, Yoichi Nakamura, Seiji Nagashima, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2010
Serum levels of surfactant protein D predict the anti-tumor activity of gefitinib in patients with advanced non-small cell lung cancerHiroyuki Yamaguchi, Hiroshi Soda, Yoichi Nakamura, et al.
Glycobiology|September 22, 2010
High-sensitivity O-glycomic analysis of mice deficient in core 2 {beta}1,6-N-acetylglucosaminyltransferasesMohd Nazri Ismail, Erica L Stone, Maria Panico, et al.
Journal of Clinical Medicine|April 11, 2020
Prediction of Anti-Cancer Drug-Induced Pneumonia in Lung Cancer Patients: Novel High-Resolution Computed Tomography Fibrosis ScoringHiroshi Gyotoku, Hiroyuki Yamaguchi, Hiroshi Ishimoto, et al.
Cancer Chemotherapy and Pharmacology|September 27, 2012
Phase II study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancerMinoru Fukuda, Yoichi Nakamura, Akitoshi Kinoshita, et al.
Thoracic Cancer|February 6, 2020
S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Study protocol of LOGIK1605/JART-1501Minoru Fukuda, Soichiro Funaki, Takuya Yamazaki, et al.
Thoracic Cancer|July 8, 2016
Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B)Minoru Fukuda, Takayuki Suetsugu, Midori Shimada, et al.
Japanese Journal of Clinical Oncology|May 22, 2016
Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701Junichi Soh, Norihito Okumura, Masao Nakata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 14, 2017
Surface LAMP-2 Is an Endocytic Receptor That Diverts Antigen Internalized by Human Dendritic Cells into Highly Immunogenic ExosomesDario Armando Leone, Andrea Peschel, Markus Brown, et al.
Thoracic Cancer|July 23, 2022
Phase II study of S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART-1501 studyMinoru Fukuda, Masafumi Yamaguchi, Takuya Yamazaki, et al.
Pageof 26

Showing results (191-200 of 254) with videos related to

Sort By:
Pageof 26
Clinical Lung Cancer|January 24, 2012
Phase I and II trials of vinorelbine with carboplatin for patients 75 years of age or older with previously untreated non-small-cell lung cancerHiroshi Takatani, Yoichi Nakamura, Seiji Nagashima, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2010
Serum levels of surfactant protein D predict the anti-tumor activity of gefitinib in patients with advanced non-small cell lung cancerHiroyuki Yamaguchi, Hiroshi Soda, Yoichi Nakamura, et al.
Glycobiology|September 22, 2010
High-sensitivity O-glycomic analysis of mice deficient in core 2 {beta}1,6-N-acetylglucosaminyltransferasesMohd Nazri Ismail, Erica L Stone, Maria Panico, et al.
Journal of Clinical Medicine|April 11, 2020
Prediction of Anti-Cancer Drug-Induced Pneumonia in Lung Cancer Patients: Novel High-Resolution Computed Tomography Fibrosis ScoringHiroshi Gyotoku, Hiroyuki Yamaguchi, Hiroshi Ishimoto, et al.
Cancer Chemotherapy and Pharmacology|September 27, 2012
Phase II study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancerMinoru Fukuda, Yoichi Nakamura, Akitoshi Kinoshita, et al.
Thoracic Cancer|February 6, 2020
S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Study protocol of LOGIK1605/JART-1501Minoru Fukuda, Soichiro Funaki, Takuya Yamazaki, et al.
Thoracic Cancer|July 8, 2016
Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B)Minoru Fukuda, Takayuki Suetsugu, Midori Shimada, et al.
Japanese Journal of Clinical Oncology|May 22, 2016
Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701Junichi Soh, Norihito Okumura, Masao Nakata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 14, 2017
Surface LAMP-2 Is an Endocytic Receptor That Diverts Antigen Internalized by Human Dendritic Cells into Highly Immunogenic ExosomesDario Armando Leone, Andrea Peschel, Markus Brown, et al.
Thoracic Cancer|July 23, 2022
Phase II study of S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART-1501 studyMinoru Fukuda, Masafumi Yamaguchi, Takuya Yamazaki, et al.
Pageof 26